---
document_datetime: 2025-02-11 14:22:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kinpeygo-epar-all-authorised-presentations_en.pdf
document_name: kinpeygo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8590022
conversion_datetime: 2025-12-21 11:51:55.268959
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form            | Route of Administration   | Immediate Packaging   | Pack size                        |
|------------------|-------------------|------------|--------------------------------|---------------------------|-----------------------|----------------------------------|
| EU/1/22/1657/001 | Kinpeygo          | 4 mg       | Modified-release capsule, hard | Oral use                  | bottle (HDPE)         | 120 capsules                     |
| EU/1/22/1657/002 | Kinpeygo          | 4 mg       | Modified-release capsule, hard | Oral use                  | bottle (HDPE)         | 360 (3x120) capsules (multipack) |
| EU/1/22/1657/003 | Kinpeygo          | 4 mg       | Modified-release capsule, hard | Oral use                  | bottle (HDPE)         | 28 capsules                      |